Lifeclean Q2’2024: Focus starts to pay off

Research Update

2024-09-02

07:00

Redeye saw sales development that was far better than our expectations. Sales development compared to last year’s quarter was up 46%. Management's increased focus on the right deals has started to pay off. We have significantly increased our sales estimates for 2025/2026e while increasing costs to sustain the higher growth. We have increased our Base case to SEK 8.0 (6.7) per share and our Fair value range to SEK 3.9 – 16.2 (3.6–15) per share.

Mats Hyttinge

Analyst Q&A

Closed

Mats Hyttinge answered 2 questions.

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.